@article{132ed45c621a4aa29af216496dcebac1,
title = "Efficient: In vivo synthesis of lasso peptide pseudomycoidin proceeds in the absence of both the leader and the leader peptidase",
abstract = "Bacterial lasso peptides are made from linear ribosomally synthesized precursors by specific cleavage at the leader-core junction site of the precursor by a dedicated protease recognizing the leader, followed by cyclisation of the newly formed N-terminus of the core part with a side chain of the internal aspartic or glutamic residue catalyzed by a macrolactam synthetase. The resulting structure has a tail that is threaded and fixed inside the cycle formed. Here, we characterize a new lasso peptide, pseudomycoidin, encoded by Bacillus pseudomycoides DSM 12442. The most surprising and unique feature of pseudomycoidin is that it can be produced in vivo from the ribosomally synthesized core part by a macrolactam synthetase, in the absence of the leader protease. The minimalism of the pseudomycoidin synthesis system makes it a powerful model to generate pseudomycoidin-based lasso-peptide libraries and to study the poorly understood process of lasso formation. We detected two additional pseudomycoidin modifications: phosphorylation of a terminal residue that was previously observed in another lasso peptide, followed by glycosylation, which was not observed heretofore. We speculate that these bulky C-terminal modifications may help maintain the threaded lasso topology of the compound synthesized by the macrolactam synthetase.",
author = "Tatyana Zyubko and Marina Serebryakova and Julia Andreeva and Mikhail Metelev and Guy Lippens and Svetlana Dubiley and Konstantin Severinov",
note = "Funding Information: This work was supported by NIH RO1 grant AI117270 (to KS and Satish A. Nair) and Skoltech institutional funds to KS, and the Russian Science Foundation grant RSF 19-14-00266 to SD. MALDI MS facility became available to us in the framework of the Moscow State University Development Program PNG 5.13. We are grateful to Dr I. Ivanov (Oncolead GmbH&Co.KG, Germany), Dr T. Artamonova and Dr M. Khodorkovsky of Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia for their invaluable help. Access to the 800 MHz NMR spectrometer was provided by MetaToul (Toulouse Metab-olomics & Fluxomics facilities, http://www.metatoul.fr) as part of the French National Infrastructure for Metabolomics and Fluxomics MetaboHUB-AR-11-INBS-0010 (http:// www.metabohub.fr) and supported by the R{\'e}gion Midi-Pyr{\'e}n{\'e}es, the ERDF, the SICOVAL and the French Minister of Education & Research, who are gratefully acknowledged. Funding Information: This work was supported by NIH RO1 grant AI117270 (to KS and Satish A. Nair) and Skoltech institutional funds to KS, and the Russian Science Foundation grant RSF 19-14-00266 to SD. MALDI MS facility became available to us in the framework of the Moscow State University Development Program PNG 5.13. We are grateful to Dr I. Ivanov (Oncolead GmbH&Co.KG, Germany), Dr T. Artamonova and Dr M. Khodorkovsky of Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia for their invaluable help. Access to the 800 MHz NMR spectrometer was provided by MetaToul (Toulouse Metabolomics & Fluxomics facilities, http://www.metatoul.fr) as part of the French National Infrastructure for Metabolomics and Fluxomics MetaboHUB-AR-11-INBS-0010 (http://www.metabohub.fr) and supported by the R?gion Midi-Pyr?n?es, the ERDF, the SICOVAL and the French Minister of Education & Research, who are gratefully acknowledged. Publisher Copyright: This journal is {\textcopyright} The Royal Society of Chemistry.",
year = "2019",
doi = "10.1039/c9sc02370d",
language = "English (US)",
volume = "10",
pages = "9699--9707",
journal = "Chemical Science",
issn = "2041-6520",
publisher = "Royal Society of Chemistry",
number = "42",
}